∗Department of Gastrointestinal Surgery II, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
†Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
‡Department of Preventive Medicine, Wuhan University School of Health Sciences, Wuhan, Hubei, China
§Ultrastructural Pathology Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
||Department of Pathology, Yale University School of Medicine, New Haven, Connecticut
¶Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.
[email protected], [email protected].
Y.L.L., J.R., J.P.Y., and Z.J.Z. contributed equally to this study.
The study was approved by the Ethics Committee of Renmin Hospital of Wuhan University (approval number WDRY2020-K151). Before enrollment, the patients or their relatives were asked for verbal consent, where applicable, or such consent was waived.
This work was supported by the Talent Introduction Fund of Wuhan University Renmin Hospital (grant number NA to T.F.).
N.A. has received grant funding from Cepheid and Astex and has served as a consultant to Ethicon. N.A. has licensed methylation Biomarkers to Cepheid Inc. The other authors declare no conflicts of interest.
Guarantor of the article: Tao Fu, MD.
Specific author contributions: Y.L.L., J.R., J.P.Y. and Z.J.Z.: contributed equally to this work. T.F.: study concept and design. Y.L.L, J.R., and J.P.Y.: acquisition of data. Z.J.Z, W.Y.G., Y.G., G.M., and T.F.: interpretation of data. Y.L.L and T.F.: drafting of manuscript. N.A. and T.F.: study supervision.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.annalsofsurgery.com).
